Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D015081 |
2-Naphthylamine |
2-Naphthylamine results in increased expression of CBL mRNA | increases expression | 18247414
|
C006632 |
arsenic trioxide |
arsenic trioxide results in increased expression of CBL protein | increases expression | 19457607
|
C006632 |
arsenic trioxide |
[bortezomib results in decreased activity of CBL protein] promotes the reaction [arsenic trioxide results in increased activity of AKT1 protein] | decreases activity|increases activity|increases reaction | 19457607
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of CBL mRNA | increases expression | 18247414
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of CBL mRNA | decreases expression | 20018196
|
C400082 |
bortezomib |
[bortezomib results in decreased activity of CBL protein] promotes the reaction [arsenic trioxide results in increased activity of AKT1 protein] | decreases activity|increases activity|increases reaction | 19457607
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of CBL mRNA | increases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CBL mRNA | affects cotreatment|increases expression | 17942748
|
C097613 |
imatinib |
[tetraarsenic tetrasulfide co-treated with imatinib] results in increased expression of CBL mRNA | affects cotreatment|increases expression | 19208803
|
D007854 |
Lead |
CBL protein affects the reaction [Lead results in decreased expression of PDGFRA protein] | affects reaction|decreases expression | 17298174
|
D007854 |
Lead |
Lead results in increased phosphorylation of CBL protein | increases phosphorylation | 17298174
|
C008261 |
lead acetate |
CBL protein affects the reaction [lead acetate results in decreased expression of PDGFRA protein] | affects reaction|decreases expression | 17298174
|
C008261 |
lead acetate |
lead acetate results in increased phosphorylation of CBL protein | increases phosphorylation | 17298174
|
D008767 |
Methylmercury Compounds |
CBL protein affects the reaction [Methylmercury Compounds results in increased ubiquitination of and results in increased degradation of PDGFRA protein] | affects reaction|increases degradation|increases ubiquitination | 17298174
|
D008767 |
Methylmercury Compounds |
Methylmercury Compounds results in increased phosphorylation of CBL protein | increases phosphorylation | 17298174
|
D009538 |
Nicotine |
Nicotine results in increased expression of CBL mRNA | increases expression | 18247414
|
D010269 |
Paraquat |
CBL protein affects the reaction [Paraquat results in decreased expression of PDGFRA protein] | affects reaction|decreases expression | 17298174
|
D010269 |
Paraquat |
Paraquat results in increased phosphorylation of CBL protein | increases phosphorylation | 17298174
|
C009166 |
retinol acetate |
retinol acetate results in increased expression of CBL mRNA | increases expression | 16772331
|
C534735 |
tetraarsenic tetrasulfide |
[tetraarsenic tetrasulfide co-treated with imatinib] results in increased expression of CBL mRNA | affects cotreatment|increases expression | 19208803
|
C534735 |
tetraarsenic tetrasulfide |
tetraarsenic tetrasulfide results in increased expression of CBL mRNA | increases expression | 19208803
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CBL mRNA | affects cotreatment|increases expression | 17942748
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.90 | 11752688 15322242 14514962 |
MESH:D000015 |
Abnormalities, Multiple |
|
imatinib |
5.28 | 18322153 |
MESH:D000022 |
Abortion, Spontaneous |
|
imatinib |
6.28 | 18322153 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
4.00 | 17505938 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
7.07 | 19825857 11798837 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
7.07 | 20127859 20464547 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
7.07 | 14692618 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.67 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.43 | 16835633 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Paraquat |
3.81 | 11874814 |
MESH:D000544 |
Alzheimer Disease |
|
Nicotine |
3.28 | 16627626 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.97 | 11748828 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.12 | 19183758 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.51 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.68 | 15885639 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
9.06 | 16206674 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
9.06 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.85 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.78 | 15746008 |
MESH:D001859 |
Bone Neoplasms |
|
imatinib |
5.36 | 15867366 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
1.99 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
imatinib |
1.99 | 17614352 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.99 | 20435547 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
4.36 | 11589617 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.82 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
1.95 | 14691202 16217749 15073043 11135700 15553829 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
bortezomib |
3.96 | 16052434 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
4.94 | 19014326 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
4.14 | 12490120 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
2.06 | 20419170 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.38 | 18850075 18670907 16120746 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.74 | 20889678 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.19 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
2.89 | 17110522 17333356 15861022 11677210 16919318 16105132 17681005 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.11 | 16354765 8697196 12621046 15340226 15668235 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
1.86 | 20501625 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.08 | 14669216 17141729 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
4.22 | 12609071 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
7.44 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
imatinib |
7.44 | 18322153 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Lead |
7.44 | 19769572 |
MESH:D019465 |
Craniofacial Abnormalities |
|
lead acetate |
7.44 | 19769572 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
7.44 | 10048152 15322242 20055451 |
MESH:D003456 |
Cryptorchidism |
marker/mechanism |
|
| 20694012 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
4.13 | 15213294 |
MESH:D003704 |
Dementia |
|
Lead |
10.79 | 16140633 |
MESH:D003704 |
Dementia |
|
Methylmercury Compounds |
10.79 | 16140633 |
MESH:D002658 |
Developmental Disabilities |
marker/mechanism |
|
| 20694012 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.67 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
1.54 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.78 | 11462148 |
MESH:D020821 |
Dystonic Disorders |
|
Nicotine |
5.98 | 17881519 |
MESH:D004487 |
Edema |
|
imatinib |
7.32 | 19703484 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
7.32 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.96 | 16714409 15322242 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
3.22 | 12538720 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.05 | 10568697 9294722 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7.25 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
7.25 | 12903497 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
7.25 | 16530937 |
MESH:D020329 |
Essential Tremor |
|
Lead |
5.98 | 14594619 18007985 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.03 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
7.83 | 15073043 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
7.83 | 15345470 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.50 | 11858732 |
MESH:D005317 |
Fetal Growth Retardation |
|
Lead |
11.83 | 19769572 |
MESH:D005317 |
Fetal Growth Retardation |
|
lead acetate |
11.83 | 19769572 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
imatinib |
5.70 | 17453242 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
2.99 | 20067830 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
4.30 | 16904648 |
MESH:D005911 |
Gliosis |
|
Paraquat |
5.23 | 11124998 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.66 | 10696789 |
MESH:D006130 |
Growth Disorders |
marker/mechanism |
|
| 20694012 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
6.49 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.49 | 10048152 11294989 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.36 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.93 | 15340226 16120746 12621046 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.11 | 16959395 15340226 8697196 18606429 16354765 |
MESH:D006934 |
Hypercalcemia |
|
bortezomib |
5.48 | 18089816 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.91 | 18850075 18670907 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.85 | 16569931 16945680 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.49 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
11.53 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
Lead |
11.53 | 16780224 |
MESH:D007248 |
Infertility, Male |
|
Paraquat |
11.53 | 4850670 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
1.87 | 12878042 12200463 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.36 | 16580747 |
MESH:D007855 |
Lead Poisoning |
|
Lead |
5.98 | 16700817 |
MESH:D007859 |
Learning Disorders |
|
Lead |
5.23 | 16384672 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
2.84 | 15070760 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
10.22 | 12560223 17077332 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
bortezomib |
10.22 | 18089816 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
4.36 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
14.52 | 14633726 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
imatinib |
14.52 | 15107311 19208803 15748426 17301526 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
tetraarsenic tetrasulfide |
14.52 | 19208803 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
10.09 | 19077051 |
MESH:D007951 |
Leukemia, Myeloid |
|
imatinib |
10.09 | 17236224 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
4.43 | 16467208 19850784 20471514 17050201 16968895 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
bortezomib |
4.43 | 20471514 |
MESH:D054429 |
Leukemia, Myelomonocytic, Juvenile |
marker/mechanism |
|
| 20694012 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
3.23 | 16966277 16330433 19035177 12018890 15213294 17869043 17107899 15622746 11161223 19225113 19075265 12679006 16891316 16331271 16823087 15748426 19642359 17712046 17649720 15336539 16112521 12712474 11468182 17217047 9834237 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
4.39 | 16882451 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
imatinib |
2.83 | 16596278 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.83 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
7.44 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
7.44 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
7.44 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
5.86 | 20377131 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
5.86 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
3.37 | 15213294 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
3.37 | 11798837 19825857 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
3.37 | 18520028 20064080 20464547 18816296 20135361 20869020 6695378 18569708 17053015 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
3.37 | 19555203 11884234 |
MESH:D008223 |
Lymphoma |
|
bortezomib |
4.58 | 16098063 |
MESH:D016393 |
Lymphoma, B-Cell |
|
bortezomib |
5.35 | 16675587 |
MESH:D008527 |
Medulloblastoma |
|
bortezomib |
4.24 | 19213072 |
MESH:D008569 |
Memory Disorders |
|
Lead |
10.51 | 16384672 17263510 |
MESH:D008569 |
Memory Disorders |
|
Methylmercury Compounds |
10.51 | 18436314 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.21 | 16381670 |
MESH:D009069 |
Movement Disorders |
|
Methylmercury Compounds |
5.36 | 18436314 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
7.86 | 19549372 19417148 11468182 14977855 15949261 |
MESH:D009101 |
Multiple Myeloma |
|
bortezomib |
7.86 | 19112201 19372569 19112817 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
4.73 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
3.16 | 16105982 16882451 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.04 | 12213967 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
4.00 | 16624393 |
MESH:D009362 |
Neoplasm Metastasis |
|
imatinib |
4.02 | 15867366 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
5.45 | 11141357 |
MESH:D009369 |
Neoplasms |
|
Nicotine |
5.45 | 16365874 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
imatinib |
5.53 | 17614352 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Nicotine |
5.04 | 16365874 |
MESH:D009410 |
Nerve Degeneration |
|
Paraquat |
3.74 | 16893418 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.25 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
3.13 | 10525206 |
MESH:D010014 |
Osteolysis |
|
imatinib |
5.79 | 15867366 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
2.41 | 19769630 12452020 16624393 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
2.53 | 15580305 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.72 | 11578682 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
4.19 | 19927285 |
MESH:D010300 |
Parkinson Disease |
|
Paraquat |
2.82 | 15451049 11124998 16510128 12911755 11181820 11445065 16140633 15824117 |
MESH:D010302 |
Parkinson Disease, Secondary |
|
Paraquat |
4.47 | 16190885 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.31 | 12520081 |
MESH:D011014 |
Pneumonia |
|
Paraquat |
4.50 | 12504350 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.59 | 18163543 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
imatinib |
4.50 | 12476293 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Lead |
16.89 | 16384672 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Methylmercury Compounds |
16.89 | 18436314 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
16.89 | 11118676 11896295 11222880 11399792 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
3.17 | 19131511 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
3.17 | 17292933 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.36 | 16919318 15861022 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Paraquat |
2.92 | 16324872 17997886 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Paraquat |
3.94 | 11700416 |
MESH:D012135 |
Respiratory Sounds |
|
Paraquat |
4.10 | 11874814 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.87 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
Paraquat |
3.89 | 16458197 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
4.00 | 16646077 |
MESH:D012640 |
Seizures |
|
Nicotine |
3.81 | 17873105 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
5.51 | 10029692 19755658 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.51 | 16192470 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
4.00 | 16709447 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
3.54 | 17007042 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
3.54 | 20155912 2093021 |
MESH:D013274 |
Stomach Neoplasms |
|
imatinib |
3.54 | 15786421 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.65 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.18 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.96 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
7.79 | 19014326 |
MESH:D013964 |
Thyroid Neoplasms |
|
imatinib |
7.79 | 16940797 |
OMIM:188890 |
TOBACCO ADDICTION, SUSCEPTIBILITY TO |
|
Nicotine |
4.75 | 16720336 16785264 11259349 |
MESH:D014029 |
Tobacco Use Disorder |
|
Nicotine |
5.49 | 18305452 17979512 15735609 18041664 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
4.01 | 15213294 |
MESH:D014202 |
Tremor |
|
Lead |
5.55 | 21145352 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2-Naphthylamine |
8.55 | 11144890 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
8.55 | 20435036 11780464 12845720 12973940 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
8.55 | 17053015 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.33 | 14692618 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.66 | 12125929 |
MESH:D014657 |
Vasculitis |
marker/mechanism |
|
| 20694012 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.57 | 14671159 15869587 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.31 | 15886252 |